ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.38p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 11.13
  • 52 Week Low: 3.38
  • Currency: UK Pounds
  • Shares Issued: 57.17m
  • Volume: 0
  • Market Cap: £1.93m
  • RiskGrade: 394

Latest ShareCast News

ReNeuron reaches exosome research milestone

By Josh White

Date: Monday 04 Sep 2023

(Sharecast News) - UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant advancements in the field of exosome research on Monday.

Director dealings: Reneuron CFO makes share purchase

By Iain Gilbert

Date: Tuesday 24 Jan 2023

(Sharecast News) - Reneuron revealed on Tuesday that chief financial officer John Hawkins had acquired 100,000 ordinary shares in the AIM-listed stem cell technologies group.

ReNeuron shares tumble after first-half results

By Josh White

Date: Friday 02 Dec 2022

(Sharecast News) - Stem-cell-derived exosome technology specialist ReNeuron Group reported first-half revenue of £0.44m on Friday, up from £0.06m year-on-year, related to income from partner-funded development activities and royalty income.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ReNeuron Group Market Data

Currency UK Pounds
Share Price 3.38p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 11.13
52 Week Low 3.38
Volume 0
Shares Issued 57.17m
Market Cap £1.93m
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.00% above the market average69.00% above the market average69.00% above the market average69.00% above the market average69.00% above the market average
1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average
Price Trend
89.91% below the market average89.91% below the market average89.91% below the market average89.91% below the market average89.91% below the market average
50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average50.88% below the sector average
Income Not Available
Growth
6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average6.10% above the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page